Valneva SE
$7.21
24H
Market Cap
Volume
Supply
Price Chart
About Valneva SE - VALN
Valneva SE is a biotech company headquartered in France that specializes in the development and commercialization of vaccines for infectious diseases. They have products and candidates to address areas such as travel vaccinations and infectious diseases like Lyme disease and chikungunya.
What are Valneva SE's core values and mission statement?
Valneva SE's core values are centered on commitment to innovation, quality, and teamwork, fostering an environment driven by the pursuit of excellence in vaccine development. Their mission is to develop and commercialize vaccines that can make a meaningful impact on public health.
Who founded Valneva SE and when?
Valneva SE was founded by Franck Grimaud and Majid Mehtali in 2013.
Who leads Valneva SE?
As of the last update, Valneva SE is led by Thomas Lingelbach, who serves as the Chief Executive Officer, and Franck Grimaud, who is the President of the company.
Where is Valneva SE located, and what is its base country?
Valneva SE is headquartered in Saint-Herblain, France, which is its base country.
On which exchanges is Valneva SE traded?
Valneva SE is traded on the Euronext Paris stock exchange and also has its shares listed on the Nasdaq in the United States.
Historical data
Valneva SE (VALN) Price Live Data
The live price of Valneva SE (VALN) is $7.21, with a trading volume of 1,435 in the last 24 hours. Wrapstocks updates the VALN price in real-time. Valneva SE is down -0.62% in the last 24 hours. The company has a live market cap of $501,652,128.00 and a supply of 69,576,307 VALN stocks.
Valneva SE (VALN) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 11 hours and 24 minutes.
